IQV - IQVIA HOLDINGS INC.


172.4
1.860   1.079%

Share volume: 770,102
Last Updated: 04-01-2026
Business Services/Services – Research, Development, Testing Labs: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$170.54
1.86
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
48%
Profitability 31%
Dept financing 50%
Liquidity 13%
Performance 72%
Company vs Stock growth
vs
Performance
5 Days
3.76%
1 Month
-1.07%
3 Months
-23.50%
6 Months
-15.63%
1 Year
-1.13%
2 Year
-29.78%
Key data
Stock price
$172.40
P/E Ratio 
28.23
DAY RANGE
$169.78 - $174.27
EPS 
$7.91
52 WEEK RANGE
$134.64 - $247.04
52 WEEK CHANGE
$2.81
MARKET CAP 
38.387 B
YIELD 
N/A
SHARES OUTSTANDING 
169.700 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.63
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,306,581
AVERAGE 30 VOLUME 
$1,568,645
Company detail
CEO: Ari Bousbib
Region: US
Website: iqvia.com
Employees: 86,000
IPO year: 2013
Issue type: Common Stock
Market: NYSE
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and Asia-Pacific. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services. The Research & Development Solutions segment provides project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services.

Recent news